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Abstract
Breast cancer places a large burden on many communities, causing mortalities, and
lasting physical, mental, and financial damage. The majority of cases are not caused by a genetic
risk factor, which speaks to the importance of addressing environmental risk factors to reduce
disease burden. Bisphenol-A (BPA) is linked to increase risk for and metastasis of breast cancer.
BPA is widely used in plastics, exposing a huge portion of the United States population. This
project used the model developed for the Green Choices program to trial response to the use of
an environmental risk survey and education tool that can be utilized in a primary care setting.
Surveys and an education sheet on reducing BPA exposure was distributed virtually to pregnant
women and women with children under the age of five, a population that is highly susceptible to
the negative impacts of BPA on breast tissue. Although plastic use in participants did not show a
statistically significant reduction, response to the information was positive. Participants agreed
that they want more environmental health education from their providers and believed their
behavior would change in the future. This project would benefit from clinic-based
implementation with a larger sample size.

Keywords: breast cancer, Bisphenol-A (BPA), environmental risk assessment,
environmental health education
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Introduction
Background
Breast cancer is a pervasive issue for women around the world. Recent data from 2018,
published by the World Cancer Research Fund (2018), found the incidence of breast cancer to be
over 2 million. It is the number one cause of cancer in women worldwide and the second most
common cancer overall (World Cancer Research Fund, 2018).
Breast cancer accounts for 15.3% of all new cancer cases among women in the United
States. On average, 12.4% of women will be diagnosed with breast cancer during their lifetime
(National Cancer Institute, n.d.). In California, breast cancer is the most commonly diagnosed
cancer in females, regardless of ethnicity or race. 31.8% of newly diagnosed cancers in women
are attributed to breast cancer and 15.6% of cancer-related deaths (Killion et al., 2018). The
American Cancer Society (2019) estimates that there will be 27,700 new cases of breast cancer
diagnosed in California in 2019 and 4,560 deaths.
Besides the physical toll and potential loss of life, breast cancer also greatly affects the
psychological wellbeing of both the patient as well as her family, friends, and caregivers. Using
data from the Women’s Health Initiative, Jones et al (2015) assessed the quality of life of women
before and after a diagnosis of breast cancer using two sections of the Rand-36 assessment tool,
which asks participants to numerically rate how they feel on questions about physical and
emotional health. This study showed that when compared with pre-diagnosis levels, depressive
symptoms increased by 20% in the first six months, while physical function and mental health
both decreased in the first year. Many survivors live with a constant fear of relapse. Women were
at a higher risk of having moderate to high fear of recurrence, especially if they were younger or
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lacked social support (Koch-Gallenkamp et al., 2016). Vulnerable populations may be even more
at risk of adverse outcomes. The Breast Cancer Care in Chicago interviews showed that African
American and Latina breast cancer patients had higher levels of negative psychological effects
associated with a diagnosis of breast cancer (Tejeda et al., 2017).
Caregivers take on a tremendous job in caring for someone with cancer. A study
published by the American Cancer Society showed that caregivers were more distressed and had
higher levels of anxiety when compared to patients. Among those studied, 43.6% of caregivers
reported having at least 10 unmet needs, including receiving information on healthcare services
and emotional support (Sklenarova et al., 2015).
In additional to the impact of the disease on the mental health of a patient, her family, and
her caregivers, a cancer diagnosis can have a devastating financial impact. A study of cancer
survivors using data from the 2011 Medical Expenditure Panel Survey, which included 19.6
million participants in the United States, found that 28.7% of cancer survivors reported having
financial burdens (Kale & Carroll, 2016). Financial burden was defined as having to borrow
money, declare bankruptcy, worry about paying for bills or visits, or making financial sacrifices.
This financial burden also increased depressive symptoms and concern about cancer recurrence
(Kale & Carroll, 2016). A survey by The Pink Fund (2017), a nonprofit charity that provides
financial assistance for breast cancer patients, found that 47% of breast cancer patients had to use
their retirement savings to pay for treatment and 41% skipped treatment or medication due to the
inability to pay.
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Problem Description
Given the devasting impact of the disease, researchers, policy makers, and advocates
need to more closely evaluate the risk factors associated with the disease. Contrary to popular
belief, family history and genetics do not play the strongest role in developing breast cancer.
According to the American Cancer Society (2017), eight out of ten women who get breast cancer
do not have a family history of breast cancer. There are many known modifiable and nonmodifiable risk factors (American Cancer Society, 2017).
Risk Factors
The Centers for Disease Control and Prevention (CDC) separates risk factors into two
categories, modifiable and nonmodifiable (CDC, 2018). Nonmodifiable risk factors include age,
genetic mutations, reproductive factors like early menstruation and menopause, breast density,
family or personal history of breast cancer, and radiation therapy (Centers for Disease Control
and Prevention, 2018). Genetic mutations also greatly influence an individual’s risk. It is
estimated that women with the BRCA1 and BRCA2 gene mutations have a greatly increased risk
of developing breast cancer, estimated at 72% and 69% (U.S. Breast Cancer Statistics, n.d.).
Nonmodifiable factors are difficult to mitigate, but monitoring modifiable risk factors may
reduce risk. Modifiable risk factors are: sedentary lifestyle, obesity, hormone replacement
therapy, reproductive factors including age at first live birth, nulliparity, and breastfeeding, and
drinking alcohol. It is estimated that 42% of all cancers and 45.1% of cancer mortalities are
attributable to modifiable risk factors (Islami et al., 2018).
The National Institute of Environmental Health Sciences (NIEHS), which researches the
interaction between environmental exposures and human health, has indicated that
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environmental exposures may influence breast cancer risk; they further emphasize the need for
more research in areas of the country with unusually high incidence rates (NIEHS, 2018). The
World Health Organization and International Agency for Research on Cancer stated that 7-19%
of cancer may be attributed to toxic chemical exposure in the environment (Goodson et al.,
2015). A study conducted on 85 examples of chemicals showed that 59% had low-dose effects,
which over time or in combination with other chemicals, may contribute to cancer incidence
(Goodson et al., 2015).
Bisphenol-A
Bisphenol-A (BPA) is a largely produced chemical that is present in a wide-range of
products. BPA is used in polycarbonate plastics, which are used in food packaging, baby bottles,
water bottles, and medical equipment. BPA is also used to produce epoxy resins, which line food
cans and water pipes (National Institute of Environmental Health Sciences [NIEHS], 2019). BPA
is also found in other products, including dental fillings and receipts (Shafei et al., 2018a). BPA
resembles an estrogen receptor agonist and can bind with estrogen receptors in the body (Shafei
et al., 2018b). Chemicals that display this ability are classified as endocrine disrupting chemicals
(EDCs) and have the potential to interfere with the endocrine system resulting in adverse health
effects (NIEHS, n.d.).
The American public is heavily exposed to products containing BPA. The Centers for
Disease Control and Prevention (CDC) tested 2,517 individuals ages six and above for urinary
levels of BPA. 93% of those tested were found to have BPA in their urine (NIEHS, 2019). In a
study of breast tissue collected from 36 mastectomies and 14 breast reduction surgeries, Low
concentrations of BPA were found in 30.6% of the breast tissue samples (Reeves et al., 2018).
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This raises concern over the health effects that this wide-spread exposure is contributing
to and the lack of research supporting the safety or potential harm of the chemicals used in
everyday products. BPA has been linked to breast and prostate cancer, precocious puberty, and
other endocrine disorders, including obesity and polycystic ovary syndrome (Shafei et al.,
2018b), Only an estimated 10 to 11% of research projects by the National Institutes of Health
(NIH) and the U.S. Department of Defense (DoD) have addressed environmental risk factors for
breast cancer (NIEHS ,2013).
The Role of Primary Care Providers
Even with the available data linking environmental exposures to increased health risks,
many providers are not educating patients on their risks. There was a lack of studies into
provider barriers to provide an insight into this issue. A survey of 191 pediatric oncologists
showed that only 7% had received training on how to conduct an environmental health history,
and 92% expressed the desire for more information and training regarding environmental
exposures and cancer risk (Zachek et al., 2015). Two surveys of healthcare providers in Canada
revealed similar results. Out of 203 primary care providers, only 18.1% reported receiving
training in environmental health history, but 92% felt knowing about exposures was important
(Sanborn et al., 2019). A survey of 135 healthcare providers reported that lack of knowledge of
and confidence in discussing exposure risk were major barriers in providing environmental
education during reproductive health visits (Williamson et al., 2017). This project seeks to trial a
tool that can simplify environmental health history and education to make the use easy for
providers and patients.
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Available Knowledge
Literature Review Methods
Due to a lack of studies regarding environmental health education and behavior change,
the review of knowledge was conducted with the intention to support the development and use of
necessity of an education tool to reduce the use of BPA exposure in primary care patients. The
following PICO question was used to guide a literature review of existing research, In the
general population, how does BPA exposure impact the risk for breast cancer? A literature
review was performed using the PubMed database and the search terms ‘BPA’ and ‘breast
cancer’. Articles were originally filtered to those published within the last 10 years for relevance,
English language, and full-text available. This search resulted in 143 articles. An abstract screen
was performed and articles were excluded if they were not directly studying breast cancer
incidence and the effect of BPA on breast cancer, resulting in 59 articles. These results were then
reduced to be within the last five years to ensure that only recent evidence was included. The
articles were then screened, excluded if there was no explanation of methods, the study was not
directly related to breast cancer incidence, or if no full-text was available. 19 articles were
chosen to be included in the review of evidence, including one literature review, one study of
human participants, and 17 experimental studies using animals or cell lines (Appendix A).
Review of Evidence
A literature review of the carcinogenic potential of BPA in vivo, concluded from 38
studies that BPA can be reasonably anticipated as a human carcinogen based on animal and
genetic findings. BPA was shown to change gene expression, which can influence cancer risk far
beyond the immediate time of exposure (Seachrist et al., 2016). Only one study using human
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participants was included. Female participants in the Centers for Disease Control and
Prevention’s National Health and Nutrition Examination Survey (NHANES), provided urinary
BPA annually from 2003-2010. Women in the study self-reported whether they were diagnosed
with breast cancer during that time. There was no significant association found between breast
cancer and BPA urinary levels (adjusted odds ratio [OR], 95% confidence interval [CI] 0.76,
0.73). However, the authors discuss the need for more comprehensive research (Morgan, Deoraj,
Felty, & Roy, 2017). The following studies review more specific influences of BPA on normal
and malignant breast cells.
Animal Studies. Changes in normal mammary tissue was shown in two studies using
rats. One study using rats (n=22), sought to investigate the impact of perinatal BPA exposure in
offspring at 22, 100, and 400 days after birth. At 0.25mg/kg, a low dose, male rats showed an
increase in mammary development (p=0.05) and female rates showed intraductal hyperplasia
(p=0.017) (Mandrup, Boberg, Isling, Christiansen, & Hass, 2016). A case-control study using
female albino rats (n=30) exposed to 5mg/kg of BPA a day for 8 weeks showed hyperplasia of
mammary epithelial cells and ducts, and increased proliferation of mammary glands (p=0.0001)
(Ibrahim, Elbakry, & Bayomy, 2016).
Mice were used in a study by Palacios-Arreola, (2017), to evaluate if prior BPA exposure
affected tumor growth. Mice were injected with breast cancer cells, 4T1, to induce tumor growth.
Those that had been exposed to one dose of 250 micrograms per kilogram of BPA at the start of
the study had 88% larger tumors (p=0.007), and a decrease in the release of pro-inflammatory
chemicals which would regulate tumor growth, interferon-gamma (p=0.0034) and tumor necrosis
factor-alpha (p=0.0244) (Palacios-Arreola, Nava-Castro, Del Río-Araiza, Pérez-Sánchez, &
Morales-Montor, 2017).
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Cell Lines. A study using three different cells lines in vitro, including MCF-7 for breast
cancer, exposed cells to levels of BPA commonly found in food (Hernandez-Hernandez et al.,
2019). BPA was shown to be cytotoxic to MCF-7 cells above 50mcg/mL. The authors estimated
the average daily exposure of BPA to be above 5.7mcg/day (Hernandez-Hernandez et al., 2019).
4-methyl-2,4-bis(4-hydroxyphenyl) pent-1-ene (MBP) is a metabolite of BPA that is formed in
the human body which was previously shown to be a more potent influencer of estrogenic
activity than BPA itself (Hirao-Suzuki, Takeda, Okuda, Takiguchi, & Yoshihara, 2019). When
exposed to MBP, the MCF-7 cell line proliferated in a dose-dependent manner. MBP also caused
downregulation of the ERα protein (Hirao-Suzuki, Takeda, Okuda, Takiguchi, & Yoshihara,
2019).
A study using HeLa cells demonstrated that BPA induced instability in chromosomes and
other defects in the cells that may lead to breast cancer development (Kim, Gwon, Kim, Choi, &
Jang, 2019). This study demonstrated that beyond being an endocrine disrupting chemical, BPA
can act in other ways to disrupt normal cell growth.
GPER Pathways. A study using Bovine vascular endothelial cells (BVECs) and breast
cancer cells (SkBr-3 and MDA-MB-231) were used to evaluate the effect of BPA on G-protein
estrogen receptors (GPER) (Xu et al., 2017). Vascular endothelial cells were studied because
they can undergo angiogenesis, encouraging malignant cell growth. GPER may act
independently of the more commonly known estrogen receptors, and may contribute to ERbreast cancer. Cells exposed to BPA were shown to have increased proliferation and migration of
the BVECs and tumor growth in the breast cancer cell lines. BPA also triggered an increase
vascular endothelial growth factor (VEGF), through the GPER pathway, an angiogenic cytokine
that can be released by malignant cells to promote growth (Xu et al., 2017).
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A study of three breast cancer cells lines, MDA-MB-231, MCF10A, and MCF12A, was
conducted to determine the effects of BPA (Castillo Sanchez, Gomez, & Perez Salazar, 2016).
While BPA was not found to be cytotoxic, there were changes made in the cells when exposed to
BPA. Through GPER, 1 µM of BPA induced the migration of MDA-MB-231 cells (P<0.05).
These findings show that low doses of BPA can induce cell changes which made lead to breast
cancer (Castillo Sanchez, Gomez, & Perez Salazar, 2016).
Nanomolar BPA triggered proliferation of estrogen positive (MCF-7) and negative
(SkBr3) breast cancer cells (Song et al., 2015). Proliferation was found to occur independent of
both ER and GPER pathways, but was increased by estrogen related receptors (ERR) (p<0.05 at
24 hours and p<0.01 at 48 hours) (Song et al., 2015).
Breast Cancer Subtypes. A study using estrogen-receptor negative inflammatory breast
cancer (IBC) cells, found that cells exposed to BPA had increased epidermal growth factor
receptor (EGFR) activation and proliferation (p<0.05), a characteristic of IBC (Sauer at al.,
2017). EGFR activation promotes tumor growth and proliferation. Treatment of IBC includes the
use of EGFR inhibitor medications, so BPA may influence resistance to this treatment (Sauer at
al., 2017).
Ductal carcinoma in situ (DCIS) can lead to the development of breast cancer in 20-50%
of those affected (Kim, Kim, Piao, & Moon, 2019). A study using estrogen-receptor negative
(ER-), progesterone-receptor negative (PR-), and human epidermal growth factor receptor
negative (HER2-) DCIS cells, in vitro and in vivo, using mice, were examined to evaluate the
effect of varying doses of BPA. Cells exposed to BPA were found to have 291 genes that were
altered in their expression. BPA promoted proliferation and migration of DCIS cells and
macrophages which may lead to tumor growth (at 24 hours, p<0.0001, at 48 hours, p=0.0008, at
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72 hours, p=0.0003). The in vivo cells were exposed to a similar level of BPA that is commonly
found in drinking water, which led to an increase in tumor size (592.1 ± 87.02 mm³ vs 361.5 ±
66.90 mm³, p=0.0619) (Kim, Kim, Piao, & Moon, 2019).
A study of triple-negative breast cancer (TNBC) cells, using the cell lines MDA-MB-231
and BT-549, showed that BPA influences the cells in this aggressive form of breast cancer as
well. BPA exposure increased motility and the expression of matrix metalloproteinases (p<0.01),
which allows for migration of the TNBC cells (Zhang, Liu, Weng, & Wang, 2016).
Genes and Proteins. A study using immature mammary epithelial cells, MCF10A,
showed that BPA influences the response of these cells to bone morphogenetic protein 2 (BMP2)
and 4 (BMP4) (Clément et al., 2017). BMP2 and BMP4 are growth factors that stimulate tumor
cell growth through signaling pathways that are found in breast cancer. Low-dose, chronic BPA
exposure pre-activated BMP signaling through alteration of receptors (p=0.02) (Clément et al.,
2017).
MCF7 in vitro cells and in vivo, in rats, showed a 9.4 fold increase in homeoboxcontaining gene, HOXB9, expression when exposed to 100 nM BPA. HOXB9 is involved in
normal mammary gland development and its alteration has been linked to breast cancer, and
tumor metastasis (Deb et al., 2016). Another homeobox-containing gene, HOXC6, has been
found to be overexpressed in breast cancer cells. BPA increased the expression of HOXC6 in
vitro and in vivo by over 4% (p<0.05) (Hussain et al., 2015).
Estrogen receptor negative (ER-) breast cancer cells were studied in vitro, using SkBr3
and MDA-MB-231 cell lines (Zhang, Wang, Liu, & Ge, 2016). ER- breast cancer is more often
associated with a worse outcome, metastasis and relapse. BPA exposure resulted in
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downregulation of forkhead-box protein A 1 (FOXA1), which prompts mesenchymal transition
(EMT), allowing for cell migration (at 6 hours, p<0.05, from 12-48 hours, p<0.01). In addition to
FOXA1, BPA exposed cells showed downregulation of one other gene and upregulation of 12
genes that are associated with breast cancer (Zhang, Wang, Liu, & Ge, 2016).
BPA Alternatives. In one case-control study, MCF-7 breast cancer cells were exposed to
BPA, and the alternatives that have been developed, bisphenol-S (BPS) and bisphenol-F (BPF)
(Kim at al. (Choi), 2017). The control, estradiol, and BPA, BPS, and BPF increased proliferation
of the MCF-7 cells. Cells exposed to BPA, BPS, and BPF showed increased migration (P<0.05),
and also changes in gene expression (P<0.05) (Kim at al. (Choi), 2017). This study shows that
alternative products related to BPA may function in a similar fashion and increase the risk for
breast cancer.
Rationale
The Health Belief Model (HBM) (Appendix B) guided the development of this project.
The HBM explains how a person’s perception of an illness and their belief in an intervention
influences their health behavior (LaMorte, W, 2019). The model is based on six constructs:
perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cue to action,
and self-efficacy. Perceived susceptibility is the individual’s belief of their personal risk for
illness and perceived severity is their belief of the seriousness of the illness. Perceived benefits
are the personal beliefs of how the suggested action will positively impact the individual’s risk
for illness. Perceived barriers are the individual’s beliefs about what stands in their way of
implementing the suggested action or change. The cue to action is the prompt to the individual to
initiate change and self-efficacy is the individual’s confidence in their behavior (LaMorte, W,
2019).
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In relation to the proposed project, a patient will consider their own potential
susceptibility to breast cancer when considering their exposure to BPA, the benefits of
implementing the changes suggested in the education sheet, and their own barriers to making the
changes. The education sheet will act as the cue to action to encourage participants to initiate
change in their lives. Considering these constructs allows for the development of a pertinent
education tool that encourages behavior changes that are attainable for the population.
Specific Aims
The AIM statement created to guide this quality improvement project is, by May 2020, a
survey of BPA exposure and education sheet with included tips for reducing exposure will be
utilized to influence behavior change, with a goal of 20 individuals participating. By July 2020, a
brief education module detailing the intervention and outcomes will be administered to current
and recent graduates of the University of San Francisco DNP program and a provider from
Native American Health Center. The target population is pregnant women and mothers with
children under the age of five. This aim statement was accomplished through the completion of
the following goals. The project was completed in July 2020.
1) A pre-survey will be used to assess the patient’s current knowledge of BPA, their risk
for exposure, and desire for environmental health education.
2) An education sheet will be provided that includes a brief description of the influence
of BPA exposure on health risks and simple tips to avoid exposure in daily life.
3) A post-survey will be used to measure knowledge attainment, desire to implement
behavior changes, and likelihood of recommending behavior change to others.
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4) A short education module will be developed and distributed to fellow primary care
providers and DNP students to introduce environmental risk assessment and
education in the primary care setting, including results from the surveyed population.

Methods
Context
The setting and stakeholders of this project have been impacted by the COVID-19
pandemic. The original setting used to assess need and chosen for implementation was a
federally qualified health center in Oakland, CA named Native American Health Center
(NAHC). The gap analysis and SWOT analysis were performed based on the current practices
and patient population at NAHC. To adjust to the social distancing and shelter in place orders, a
virtual platform was utilized to distribute the surveys and education tool. The stakeholders of this
project were then adjusted to be this DNP student, the chair and co-chair of the project
committee, and the primary care provider representing NAHC.
Intervention
Gap Analysis
A gap analysis (Appendix C) revealed that the current practice at NAHC does not include
a tool or standard practice for assessing environmental risk. With short primary care
appointments, providers may find it challenging to provide thorough preventative care or provide
concise, usable information about exposures. The desired state of practice would allow providers
access to a tool that is well-received by patients and easy to implement. The plan for this project
is to trial a simple, quick, and effective environmental risk assessment and education tool.
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SWOT Analysis
A SWOT (strengths, weaknesses, opportunities, threats) analysis was conducted for this
project (Appendix D). An important strength is first and foremost determining if there is interest
in this kind of information in the primary care setting. The survey was designed to provide
results that support the need and demand for implementing environmental health education into
standard preventative care. Other strengths include providing the information to the target
population and increasing the quality of care. This project provides the opportunity to increase
communication about environmental risk factors and the need for action to prevent negative
health outcomes due to exposure. The information is provided in a community setting, so there is
opportunity for greater dissemination through participants telling their family and friends.
Weaknesses include implementation in the virtual setting related to COVID-19 restrictions, data
that is reliant on self-reporting, and the time constraints of short primary care appointments. It
can be difficult to provide thorough education and assessment during an appointment with a very
limited time period, when there may be more acute issues to address. Threats to the success of
the project include the populations’ perceived susceptibility to exposures and disease, and the
availability of resources to the target population to implement desired change. There is also the
threat of perceived importance by providers who may not prioritize exposure risk during visits.
Purpose and Processes
To address the need for the reduction of environmental exposures, elements of the Green
Choices program developed by Planned Parenthood and the Rethink Plastic pilot study were
utilized. The Green Choices program was developed to address increasing rates of reproductive
cancers and decreasing fertility rates (Worthington, Armstrong, & Debevec, 2010). The surveys
and education sheets were developed by an advisory committee comprised of environmental and
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reproductive health experts to address the most common exposures. The included exposures
were: plastics, personal care products, fruits and vegetables, fish, lead, pesticides, cleaning
products, and tobacco smoke. The material was written to be at a 6th grade reading level, based
on the recommendation of a literacy expert (Worthington, Armstrong, & Debevec, 2010).
The Rethink Plastic Pilot study was conducted by Plastic Pollution Coalition, Child
Health and Development Studies, and California’s Breast Cancer Research Fund to evaluate if
education could impact behavior change and decrease estrogenic activity in the body (Curtis,
2018). This study provided participants with an education session about the dangers of exposure
to plastics and BPA, and tips to reduce their daily exposure. The results showed that participants
successfully decreased their use of plastics, shared the information with family and friends, and
had a decrease in estrogenic activity (Curtis, 2018).
The target population of pregnant women and women with children under 5 years of age
was selected based on the theory that exposures pose a greater risk during certain periods of
susceptibility. When discussing breast cancer risk, pregnancy is identified as a period of
susceptibility for the mother due to growth and changes in breast tissue, and for the fetus,
especially during the embryonic stage when breast tissue is developing (Terry et al., 2019). The
World Health Organization (2011), stated that the impact of environmental exposures may be
greater in early life due to the rapid growth of children during this time period. The effects of
early exposure may also negatively impact health and developmental later in life (World Health
Organization, 2011).
The initial portion of the project included a pre-survey to assess interest and risk of
exposure, an education tool introducing the health risks of BPA and how to reduce exposure, and
a post-survey that assessed behavior change and knowledge attainment. The pre-survey
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(Appendix E) included five questions to assess plastic exposure that were used in the Green
Choices program. Additional questions were included to gauge interest and assess if the
population had received education on environmental risks from their primary care provider prior
to this intervention. Participants then read the Green Choices handout on plastics and an
education sheet on the health risks associated with BPA exposure (Appendix F). The education
sheet encourages participants to think of their susceptibility, the severity of this exposure, and
acts as a cue to action for a positive change. After two weeks, the participants were sent a postsurvey with the same Green Choices questions to evaluate behavior change, in addition to
questions about knowledge attainment and dissemination (Appendix G). Demographic questions
were included in the follow-up survey to provide anonymity. Free text spaces were available for
participants to add feedback that cannot be expressed through the survey questions. The Green
Choices education sheets about the remaining exposures covered by the program were included
in the follow-up email to provide additional information and allow for broader dissemination.
After results were collected, a brief training module was developed for providers,
including current or recently graduated DNP students. This module presented results from the
pilot survey, provided the resources used, and explained ideas for implementation in a primary
care clinic in a PowerPoint presentation that was sent through email. The module was shared
with the primary care provider, and nurse practitioner preceptor, from NAHC who then
disseminated it within the organization.
Implementation
The components of the development, implementation, and analysis plan are demonstrated
in the work breakdown structure (Appendix H). This breakdown of tasks was used to detail the
schedule in the included GANTT chart (Appendix I). The plan for this project was changed and
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redeveloped due to the COVID-19 pandemic and shelter in place order. The planning and
development phase started early in April 2020. The surveys and education sheet were completed
April 6, 2020 and approved by the project chair and co-chair on April 8, 2020. The
implementation phase began April 10, 2020 with the distribution of pre-surveys and the plastics
information sheet. Post-surveys were distributed on April 28, 2020. Results were analyzed in
May 2020 and presented to providers in an education module, distributed in July 2020.
Through the development, implementation, and analysis of this project, communication
was maintained between the DNP project lead, chair and co-chair. This is detailed in the
communication matrix (Appendix J). Communication consisted of virtual communication, to
ensure social distancing. Zoom, phone calls, and email will be utilized to maintain open
communication and allow for feedback from the chair and co-chair. The nurse practitioner
preceptor from Native American Health Center was utilized and involved in the dissemination of
the education module to primary care providers.
The budget (Appendix K) was based on time spent with development and potential
training for staff. The approximate starting hourly pay for a nurse practitioner at Native
American Health Center is $48/hr. The development of the education tool and survey took about
20 hours, totaling $960 cost. This project was conducted virtually, so there is no cost for
materials. If this was being implemented in the clinic as originally planned, there would be
additional cost for printing materials and training a medical assistant to assist with
implementation. This means the total project cost was estimated as $960.
The return on investment varies based on the wide range of health effects attributed to
BPA exposure. In a report by MD Anderson, the average treatment for breast cancer cost patients
$2,727 and the average cost to insurance was $82,260, but varies as much $20,354. This huge
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burden on patients and health care systems justifies the implementation of a simple tool that may
decrease this burden.
Outcome Measures
The outcome for both the education tool with the general population and the education
module for providers was conducted through online surveys. The general population received a
pre- and post-survey, while providers completed a post-survey. There were a few main goals for
each target group that were achieved through the use of surveys. The general population surveys
measured risk for exposure in everyday life, the desire for environmental health education, and
behavior change after the intervention. The risk assessment questions were developed by
Planned Parenthood, and were included in the post-survey to measure behavior change. The
provider surveys will measure attitudes towards environmental exposure risk assessment and
education and knowledge attainment. Providers will also be provided a space to discuss potential
barriers to implementing environmental health risk assessment and education in their practice.
Analysis
Surveys were administered using Survey Monkey. Survey Monkey provides statistical
overview of results, and tools for data analysis, including confidence interval and statistical
significance (Survey Monkey, n.d.). Answers were assigned a numerical value for analysis, with
regularly being a 3, sometimes a 2, and never a 1. Results were then exported to an Excel
spreadsheet to perform a statistical analysis. Analysis included mean values from the pre- and
post-survey questions, and standard deviations. A Kolmogorov-Smirnov test was performed,
p<0.0001, which determined the sample population does not follow a normal distribution. Based
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on the departure from normality and unpaired survey results, the non-parametric Mann-Whitney
U test was performed to determine statistical significance with α=0.05.
Ethical Considerations
This project is designed to be in line with the Jesuit values that are held by the University
of San Francisco. Cura personalis is the Jesuit value meaning the care of the whole person
(University of San Francisco, n.d.). Environmental risk assessment demonstrates caring for the
physical aspect of an individual, while providing flexible tips for lowering exposure cares for
ones’ autonomy and intellect. The project is developed to educate, and lead participants towards
healthy choices. It does not penalize actions or designate one choice as ‘bad’. To care for the
whole person is to respect their whole being.
The American Nurses Association developed a Code of Ethics to guide nursing care. The
Code is comprised of nine provisions (American Nurses Association, 2015). While all of the
provisions guide this project, provision two and three were especially impactful. Provision two
states that the primary commitment of a nurse is to the patient, or population (American Nurses
Association, 2015). Introducing environmental risk assessment and education into primary care
shows a commitment to increasing the quality of preventative care and decreasing the health
risks in the patient population. Provision three states that the “nurse promotes, advocates for, and
protects the rights, health, and safety of the patient”. (American Nurses Association, 2015, p.v.).
Environmental health involves a great deal of advocacy for safer products and more choices. The
goal is to protect the health and safety of the general population, especially from exposures they
may not realize are risks to their health.
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This project has been approved as a quality-improvement project and does not need IRB
approval for research (Appendix L). In the development of this project, participant privacy was
respected by using anonymous surveys. This encourages truthful responses and protects results
from being identified. The education sheet is written in a way that makes the tips accessible for
those of varying socio-economic levels and is written at a 6th grade reading level to ensure all
participants can understand the information.
Results
Population
Due to limitations caused by the COVID-19, this project was implemented virtually.
Family and friends who fell into the target population of pregnant women and women with
children under the age of five were emailed the surveys and education sheet. Participants were
encouraged to share the information. The pre-survey was completed by 24 participants, three of
which identified as pregnant and 21 as having a child or children under the age of five.
Demographics were obtained in the post-survey to ensure anonymity, which was completed by
21 participants (Appendix M). The majority of participants identified as White, 20 of 21, and one
identified as Asian. The most common living community was suburban, as identified by 14
participants. Followed by six participants living in an urban environment and one in a rural
community. Ten participants identified their annual household income as between $100,000 and
$150,000, seven participants had an annual household income of above $150,000, and the
remaining four participants had an income between $50,000 and $100,000.
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Participant Surveys
Interest in learning about risks to personal health in their environment was expressed by
100% of participants in the pre-survey. When asked if a healthcare provider had previously
provided them with education about environmental health risks, 70.83% of participants indicated
they had never received information. The majority of participants, 85.71%, indicated they would
like their provider to provide more environmental health education during their own or their
children’s primary care visits. The majority of participants also indicated that this education
handout increased their knowledge of plastics and how to reduce exposure, 95.24%, and that
they felt their behavior would change if they were provided more information, 85.71%. One
participant commented that it would be helpful to them in the future to have more information
presented in a similar way as the handout, indicating it was an easy and quick reference for better
choices. Three participants shared this information with friends or family, totaling 14 additional
contacts. Both surveys took an average of one minute to complete.
Table 1 includes the mean of the answers from both the pre- and post-surveys and
standard deviations. The post-intervention surveys showed a slight decrease in mean. Although,
the p-values from the Mann-Whitney U test do not show a statistically significant change, this
may be a result of the small sample size. Results from both the pre- and post-surveys are
included in Appendix N.
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Table 1
Question

Pre-Survey Mean

Post-Survey Mean

Mann-Whitney, p-

(Standard Deviation)

(Standard Deviation)

value (α=0.05)

I (or my family)

1.875

1.857

0.864

microwave food

(0.612371)

(0.654654)

I (or my family)

2.166667

2.142857

eat food that

(0.56466)

(0.573212)

I (or my family)

2.375

2.238095

drink from

(0.646899)

(0.70034)

I (or my family)

2.416667

2.25

store food in

(0.583592)

(0.638666)

My take-out

2.333333

2.285714

comes in plastic

(0.56466)

(0.560612)

in plastic
containers or
use plastic wrap
0.856

comes from a
can (soups,
beans, baby
formula, etc)
0.485

plastic bottles or
cups
0.353

plastic
0.741
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Provider Survey
The provider survey was completed by two primary care providers, one recent DNP
graduate, and three current DNP students. This survey was conducted to measure the response of
providers to the environmental risk assessment tool and education sheet. Three participants
indicated they had previously received training on assessing environmental health risks, while
two had never received training, and one neither agreed or disagreed. Four of the six providers
had never received training on educating patients on environmental health. Five of the current
and future providers included in the study indicated that they would implement Green Choices or
a similar program in their practice, and 100% agreed that the information would be beneficial for
the populations they care for. When asked about potential barriers in implementation, two
participants said they did not see any barriers to implementation, while the remaining
participants identified staff availability, time, training, motivation or personal health beliefs, and
ability of patients to access resources. See Appendix
Discussion
Summary
The goal for this project was to identify a quick and efficient tool for assessing
environmental risks to primary care patients and provide them with education for risk reduction.
A total of 24 participants that were either pregnant or have children under the age of 5 completed
the pre-survey and read the education sheet. A total of 21 of the original 24 participants
completed the post-survey. Using the results, one primary care provider and three DNP students
were educated on the use of the Green Choices tool and possible implementation in a primary
care clinic setting. The aim statement was completed, along with the four identified goals. The
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response sent to the survey population was robust, obtaining more than the identified goal of 20
participants.
Interpretation
The surveyed population expressed overwhelming interest in receiving environmental
health education in their own or their children’s primary care visits. The survey completion time
was an average of one minute which makes this a plausible survey tool for a primary care clinic.
The survey could be administered to the patient by the medical assistant, and given the
appropriate education sheets. The provider would be able to briefly review the education and
reinforce the potential risks to their health. Survey participants responded positively to the
provided education and believed they would change their behavior if they had more information
on their risk factors. This infers that an assessment tool and education sheet is an effective cue to
action for the population, encouraging participants to consider their susceptibility, the benefits of
changing their behavior, and the severity of consequences. In the context of BPA exposure, the
education sheet provided a simple scale to identify plastics with a higher risk for BPA exposure
and simple suggestions to reduce use. The primary care providers for NAHC did not identify any
barriers to implementation and agreed that this information would benefit their patient
population, although there was concern over accessibility of alternatives for a low-income
patient population.
Although the survey did not show a statistically significant change in behavior, there
were many barriers to participants being able to implement change. These are mainly related to
the shelter-in-place orders due to the COVID-19 pandemic, and may include lack of access to
new food storage containers, and inability to frequent grocery stores resulting in continued
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canned food use. This project should be continued with a larger population in a clinic to continue
to evaluate effectiveness and interest.
Limitations
The COVID-19 pandemic has created limitations in this project. The implementation is
now virtual, and relies on the DNP project lead’s social and professional network. This decreases
the variety of demographics and socio-economic levels that can be surveyed. It can also lead to
bias in answers from participants due to personal relationships. Unfortunately, with the current
pandemic state and shelter in place orders, these limitations cannot be mitigated. However,
results can still be used as a basis to continue this project in person when possible and encourage
providers to create ways to implement this screening and education.
A major limitation in the implementation was the lack of response by providers. Only one
current primary care provider from NAHC has responded. While the surveyed DNP students and
primary care provider responded positively to the presentation, the dissemination of material was
limited. Possible reasons for this include provider burden from the COVID-19 pandemic and
lack of presence of this DNP student in the clinic.
Conclusions
This pilot project gauged interest in environmental health education in mothers and
pregnant women. This population can be especially susceptible to toxic exposures due to periods
of rapid growth and development. This project will serve as a basis to encourage a standard
practice of environmental risk assessment and education during primary care visits. In the shortterm, survey results showed the desire of the target population to receive this information from
their providers and introduced a helpful tool to providers. The population surveyed believed this

BISPHENOL (BPA) AND BREAST CANCER

31

information could impact their behavior, improving prevention of chronic disease. Research has
shown that BPA is associated with a large range of health conditions, including breast cancer and
childhood obesity. In the long-term, implementing a similar module in clinics can improve
preventative care and patient health. It will also increase patient knowledge and encourage them
to be aware of environmental health hazards. This project has the potential to be carried out in a
clinic by another DNP student or a provider who may want to be a champion of environmental
health. Through education, this population can begin to make changes to benefit their health.

Funding
The DNP project manager received two scholarships that contributed to tuition costs and
aided indirectly in the completion of this project. Jonas Philanthropies provided one scholarship
for promoting environmental health and doctoral education for nurses. The other scholarship was
the Health Resources and Services Administration (HRSA) ANEW award for working with
underserved populations at the Native American Health Center, the intended population for this
project prior to COVID-19.
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Appendix B
Health Belief Model

https://www.researchgate.net/figure/The-health-belief-model_fig1_290193215
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Appendix C
Gap Analysis
Desired State

Current State

Plan of Action

The desired state of practice

The current state of practice

The plan of action is to

is to include environmental

does not include

modify the Green Choices

risk assessment and education

environmental risk

tool developed by Planned

in primary care to decrease

assessment to everyday

Parenthood to focus on

the burden of disease and

exposures, outside of

assessing and reducing the

provide a higher quality of

allergies, or education.

risk of BPA exposure in

preventive care.

mothers and pregnant
women. The survey and
education sheet will be
distributed virtually, with the
goal of being a quick and
effective intervention. The
tips included will reduce the
exposure of BPA in patients,
therefore lowering the longterm burden of health effects,
including breast cancer and
childhood obesity.

BISPHENOL (BPA) AND BREAST CANCER

48

Appendix D
SWOT Analysis
Strengths
➢ Demonstrates interest in
environmental health
➢ Provides usable information about
BPA that affects the population
➢ Provides simple tips to reduce
exposure
➢ Increases quality of preventive care by
addressing environmental risks
Opportunities
➢ Increased communication about
environmental risk factors in the
community
➢ Improved awareness of the need for
safe products

Weaknesses
➢ Information needs to be provided in a
very short window of time (2-3
minutes)
➢ Will not provide data on physiologic
changes in patients and family
members
➢ Data collected virtually and based on
self-report
Threats
➢ Perceived importance of
environmental health
➢ Personal beliefs of patients of their
susceptibility to disease
➢ Availability of resources (ex. ability to
obtain glass containers) based on
socioeconomic status of patients
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Appendix E
Pre-Survey Questions
1. I am
a. Pregnant
b. Have a child/children under the age of 5
2. I am interested in learning about health risks in my environment
a. Agree
b. Disagree
3. I have previously received information from my provider about my environmental
health risks
a. Agree
b. Disagree
4. I (or my family) microwave food in plastic containers or use plastic wrap
a. Regularly
b. Sometimes
c. Never
5. I (or my family) eat food that comes from a can (soups, beans, baby formula, etc)
a. Regularly
b. Sometimes
c. Never
6. I (or my family) drink from plastic bottles or cups
a. Regularly
b. Sometimes

BISPHENOL (BPA) AND BREAST CANCER
c. Never
7. I (or my family) store food in plastic
a. Regularly
b. Sometimes
c. Never
8. My take-out comes in plastic
a. Regularly
b. Sometimes
c. Never
9. My email for a follow-up survey in two weeks is: __________
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Education Sheets
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Appendix G
Post-Survey Questions
1. The handout increased my knowledge of plastics and how to reduce my exposure
to BPA
a. Strongly Agree
b. Agree
c. Neither agree nor disagree
d. Disagree
e. Strongly Disagree
f. Additional comments: ____________
2. I would like my provider to include more environmental health education into my
(or my child’s) primary care visits
a. Strongly Agree
b. Agree
c. Neither agree nor disagree
d. Disagree
e. Strongly Disagree
f. Additional comments: ____________
3. My behavior would change if I was provided more information about health risks
in my environment
a. Strongly Agree
b. Agree
c. Neither agree nor disagree
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d. Disagree
e. Strongly Disagree
f. Additional comments: ____________
4. I shared this information with friends or family
a. Agree
b. Disagree
c. If so, how many: _____________
5. I (or my family) microwave food in plastic containers or use plastic wrap
a. Regularly
b. Sometimes
c. Never
6. I (or my family) eat food that comes from a can (soups, beans, baby formula, etc)
a. Regularly
b. Sometimes
c. Never
7. I (or my family) drink from plastic bottles or cups
a. Regularly
b. Sometimes
c. Never
8. I (or my family) store food in plastic
a. Regularly
b. Sometimes
c. Never
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9. My take-out comes in plastic
a. Regularly
b. Sometimes
c. Never
10. The community I live in is:
a. Rural
b. Suburban
c. Urban
d. Prefer not to answer
11. My identified race is:
a. White
b. Black or African American
c. American Indian or Alaska Native
d. Asian
e. Native Hawaiian or Other Pacific Islander
f. Other
g. Prefer not to answer
12. My annual household income is
a. Under $50,000
b. Between $50,000 and $100,000
c. Between $100,000 and $150,000
d. $150,000 and above
e. Prefer not to answer
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Work Breakdown Structure
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Appendix J
Communication Plan
Activity

Timing

Communication

Involved stakeholders

method
DNP project

Weekly until project

development

implementation

Email, phone calls

DNP project leader,
DNP chair and cochair

DNP project

Monthly

implementation and

Email, Zoom, phone

DNP project leader,

calls

DNP chair and co-

progress assessment
DNP data analysis

chair, NP preceptor
Monthly

Email, phone calls

DNP project leader,
DNP chair and cochair

DNP project

Weekly as needed

Email, phone calls,

DNP project leader,

completion

until completion

Zoom meeting

DNP chair and cochair
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Appendix K
Proposed Budget
Task

Cost

Development of education tool and surveys

$960 ($48 hourly x 20 hours)

Distribution of materials

0$
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Appendix L
Statement of Determination
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Demographics
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Appendix N
Survey Results
Pre-Survey
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Post-Survey
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Provider Survey Results
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